Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.1844-1846
Hauptverfasser: Yong, Kwee, Royle, Kara-Louise, Ramasamy, Karthik, Parrish, Christopher, Hockaday, Anna, Asher, Samir, Drayson, Mark T, de Tute, Ruth M., Jenner, Matthew W, Kaiser, Martin F., Pratt, Guy, Sive, Jonathan, Bygrave, Ceri, Cook, Gordon, Popat, Rakesh, Smith, Dean, Olivier, Catherine, Barnard, Lorna, Levinte, Doina, Dawkins, Bryony, Chapman, Michael A, Chantry, Andrew D, Jackson, Graham, Quezada, Sergio A, Owen, Roger G, Cairns, David
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1846
container_issue Supplement 1
container_start_page 1844
container_title Blood
container_volume 140
creator Yong, Kwee
Royle, Kara-Louise
Ramasamy, Karthik
Parrish, Christopher
Hockaday, Anna
Asher, Samir
Drayson, Mark T
de Tute, Ruth M.
Jenner, Matthew W
Kaiser, Martin F.
Pratt, Guy
Sive, Jonathan
Bygrave, Ceri
Cook, Gordon
Popat, Rakesh
Smith, Dean
Olivier, Catherine
Barnard, Lorna
Levinte, Doina
Dawkins, Bryony
Chapman, Michael A
Chantry, Andrew D
Jackson, Graham
Quezada, Sergio A
Owen, Roger G
Cairns, David
description
doi_str_mv 10.1182/blood-2022-168842
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_168842</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122023084</els_id><sourcerecordid>S0006497122023084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1852-8ca71ca01d63e879c22b8720e6a21368afd35639aa51cecb3f714b98908f1b93</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhiMEEkvhAbjNESRMbWeTOOIU7bYFtQsoXRC3aGJPtoZsHNku1T4xr0GyCxInTiP90v_NjL4keSn4WyGUPG975wyTXEomcqWW8lGyEJlUjHPJHycLznnOlmUhnibPQvjOuVimMlskv2obfrDK4BjJwPaOPI4HWFtPeg4qrZ03dthBdFBTGN0QCF7V1bqq38CXa7apK9gcqHd7hG9fXwODlduP6OfKpl6zq3trZrAnjHsaIlwEjT1G6wbAwcCa2D_JbfQYaWcpgB3g8xROlQAPNt7BR3ro58twN7gwIf9uvb23EdueoHN-AtAeVtT300YcwtjjEI_o58mTDvtAL_7Ms2R7ebFdvWc3n64-rKobpoXKJFMaC6GRC5OnpIpSS9mqQnLKUYo0V9iZNMvTEjETmnSbdoVYtqUquepEW6ZniThhtXcheOqa0ds9-kMjeDOLao6imllUcxI1dd6dOjTd9dOSb4Ke_tZkjhYa4-x_2r8Bm3ieMQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Yong, Kwee ; Royle, Kara-Louise ; Ramasamy, Karthik ; Parrish, Christopher ; Hockaday, Anna ; Asher, Samir ; Drayson, Mark T ; de Tute, Ruth M. ; Jenner, Matthew W ; Kaiser, Martin F. ; Pratt, Guy ; Sive, Jonathan ; Bygrave, Ceri ; Cook, Gordon ; Popat, Rakesh ; Smith, Dean ; Olivier, Catherine ; Barnard, Lorna ; Levinte, Doina ; Dawkins, Bryony ; Chapman, Michael A ; Chantry, Andrew D ; Jackson, Graham ; Quezada, Sergio A ; Owen, Roger G ; Cairns, David</creator><creatorcontrib>Yong, Kwee ; Royle, Kara-Louise ; Ramasamy, Karthik ; Parrish, Christopher ; Hockaday, Anna ; Asher, Samir ; Drayson, Mark T ; de Tute, Ruth M. ; Jenner, Matthew W ; Kaiser, Martin F. ; Pratt, Guy ; Sive, Jonathan ; Bygrave, Ceri ; Cook, Gordon ; Popat, Rakesh ; Smith, Dean ; Olivier, Catherine ; Barnard, Lorna ; Levinte, Doina ; Dawkins, Bryony ; Chapman, Michael A ; Chantry, Andrew D ; Jackson, Graham ; Quezada, Sergio A ; Owen, Roger G ; Cairns, David</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-168842</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.1844-1846</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1852-8ca71ca01d63e879c22b8720e6a21368afd35639aa51cecb3f714b98908f1b93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Yong, Kwee</creatorcontrib><creatorcontrib>Royle, Kara-Louise</creatorcontrib><creatorcontrib>Ramasamy, Karthik</creatorcontrib><creatorcontrib>Parrish, Christopher</creatorcontrib><creatorcontrib>Hockaday, Anna</creatorcontrib><creatorcontrib>Asher, Samir</creatorcontrib><creatorcontrib>Drayson, Mark T</creatorcontrib><creatorcontrib>de Tute, Ruth M.</creatorcontrib><creatorcontrib>Jenner, Matthew W</creatorcontrib><creatorcontrib>Kaiser, Martin F.</creatorcontrib><creatorcontrib>Pratt, Guy</creatorcontrib><creatorcontrib>Sive, Jonathan</creatorcontrib><creatorcontrib>Bygrave, Ceri</creatorcontrib><creatorcontrib>Cook, Gordon</creatorcontrib><creatorcontrib>Popat, Rakesh</creatorcontrib><creatorcontrib>Smith, Dean</creatorcontrib><creatorcontrib>Olivier, Catherine</creatorcontrib><creatorcontrib>Barnard, Lorna</creatorcontrib><creatorcontrib>Levinte, Doina</creatorcontrib><creatorcontrib>Dawkins, Bryony</creatorcontrib><creatorcontrib>Chapman, Michael A</creatorcontrib><creatorcontrib>Chantry, Andrew D</creatorcontrib><creatorcontrib>Jackson, Graham</creatorcontrib><creatorcontrib>Quezada, Sergio A</creatorcontrib><creatorcontrib>Owen, Roger G</creatorcontrib><creatorcontrib>Cairns, David</creatorcontrib><title>Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAQhiMEEkvhAbjNESRMbWeTOOIU7bYFtQsoXRC3aGJPtoZsHNku1T4xr0GyCxInTiP90v_NjL4keSn4WyGUPG975wyTXEomcqWW8lGyEJlUjHPJHycLznnOlmUhnibPQvjOuVimMlskv2obfrDK4BjJwPaOPI4HWFtPeg4qrZ03dthBdFBTGN0QCF7V1bqq38CXa7apK9gcqHd7hG9fXwODlduP6OfKpl6zq3trZrAnjHsaIlwEjT1G6wbAwcCa2D_JbfQYaWcpgB3g8xROlQAPNt7BR3ro58twN7gwIf9uvb23EdueoHN-AtAeVtT300YcwtjjEI_o58mTDvtAL_7Ms2R7ebFdvWc3n64-rKobpoXKJFMaC6GRC5OnpIpSS9mqQnLKUYo0V9iZNMvTEjETmnSbdoVYtqUquepEW6ZniThhtXcheOqa0ds9-kMjeDOLao6imllUcxI1dd6dOjTd9dOSb4Ke_tZkjhYa4-x_2r8Bm3ieMQ</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Yong, Kwee</creator><creator>Royle, Kara-Louise</creator><creator>Ramasamy, Karthik</creator><creator>Parrish, Christopher</creator><creator>Hockaday, Anna</creator><creator>Asher, Samir</creator><creator>Drayson, Mark T</creator><creator>de Tute, Ruth M.</creator><creator>Jenner, Matthew W</creator><creator>Kaiser, Martin F.</creator><creator>Pratt, Guy</creator><creator>Sive, Jonathan</creator><creator>Bygrave, Ceri</creator><creator>Cook, Gordon</creator><creator>Popat, Rakesh</creator><creator>Smith, Dean</creator><creator>Olivier, Catherine</creator><creator>Barnard, Lorna</creator><creator>Levinte, Doina</creator><creator>Dawkins, Bryony</creator><creator>Chapman, Michael A</creator><creator>Chantry, Andrew D</creator><creator>Jackson, Graham</creator><creator>Quezada, Sergio A</creator><creator>Owen, Roger G</creator><creator>Cairns, David</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation</title><author>Yong, Kwee ; Royle, Kara-Louise ; Ramasamy, Karthik ; Parrish, Christopher ; Hockaday, Anna ; Asher, Samir ; Drayson, Mark T ; de Tute, Ruth M. ; Jenner, Matthew W ; Kaiser, Martin F. ; Pratt, Guy ; Sive, Jonathan ; Bygrave, Ceri ; Cook, Gordon ; Popat, Rakesh ; Smith, Dean ; Olivier, Catherine ; Barnard, Lorna ; Levinte, Doina ; Dawkins, Bryony ; Chapman, Michael A ; Chantry, Andrew D ; Jackson, Graham ; Quezada, Sergio A ; Owen, Roger G ; Cairns, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1852-8ca71ca01d63e879c22b8720e6a21368afd35639aa51cecb3f714b98908f1b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yong, Kwee</creatorcontrib><creatorcontrib>Royle, Kara-Louise</creatorcontrib><creatorcontrib>Ramasamy, Karthik</creatorcontrib><creatorcontrib>Parrish, Christopher</creatorcontrib><creatorcontrib>Hockaday, Anna</creatorcontrib><creatorcontrib>Asher, Samir</creatorcontrib><creatorcontrib>Drayson, Mark T</creatorcontrib><creatorcontrib>de Tute, Ruth M.</creatorcontrib><creatorcontrib>Jenner, Matthew W</creatorcontrib><creatorcontrib>Kaiser, Martin F.</creatorcontrib><creatorcontrib>Pratt, Guy</creatorcontrib><creatorcontrib>Sive, Jonathan</creatorcontrib><creatorcontrib>Bygrave, Ceri</creatorcontrib><creatorcontrib>Cook, Gordon</creatorcontrib><creatorcontrib>Popat, Rakesh</creatorcontrib><creatorcontrib>Smith, Dean</creatorcontrib><creatorcontrib>Olivier, Catherine</creatorcontrib><creatorcontrib>Barnard, Lorna</creatorcontrib><creatorcontrib>Levinte, Doina</creatorcontrib><creatorcontrib>Dawkins, Bryony</creatorcontrib><creatorcontrib>Chapman, Michael A</creatorcontrib><creatorcontrib>Chantry, Andrew D</creatorcontrib><creatorcontrib>Jackson, Graham</creatorcontrib><creatorcontrib>Quezada, Sergio A</creatorcontrib><creatorcontrib>Owen, Roger G</creatorcontrib><creatorcontrib>Cairns, David</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yong, Kwee</au><au>Royle, Kara-Louise</au><au>Ramasamy, Karthik</au><au>Parrish, Christopher</au><au>Hockaday, Anna</au><au>Asher, Samir</au><au>Drayson, Mark T</au><au>de Tute, Ruth M.</au><au>Jenner, Matthew W</au><au>Kaiser, Martin F.</au><au>Pratt, Guy</au><au>Sive, Jonathan</au><au>Bygrave, Ceri</au><au>Cook, Gordon</au><au>Popat, Rakesh</au><au>Smith, Dean</au><au>Olivier, Catherine</au><au>Barnard, Lorna</au><au>Levinte, Doina</au><au>Dawkins, Bryony</au><au>Chapman, Michael A</au><au>Chantry, Andrew D</au><au>Jackson, Graham</au><au>Quezada, Sergio A</au><au>Owen, Roger G</au><au>Cairns, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>1844</spage><epage>1846</epage><pages>1844-1846</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-168842</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.1844-1846
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_168842
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A46%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk-Adapted%20Therapy%20Directed%20According%20to%20Response%20(RADAR,%20UK-MRA%20Myeloma%20XV)%20-%20Comparing%20MRD-Guided%20Treatment%20Escalation%20and%20De-Escalation%20Strategies%20in%20Patients%20with%20Newly%20Diagnosed%20Myeloma%20Suitable%20for%20Stem%20Cell%20Transplantation&rft.jtitle=Blood&rft.au=Yong,%20Kwee&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=1844&rft.epage=1846&rft.pages=1844-1846&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-168842&rft_dat=%3Celsevier_cross%3ES0006497122023084%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122023084&rfr_iscdi=true